Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Weight loss drug reduces CV risks | HCM may be widely underdiagnosed | TAVR controversy leads to lawsuit
Wednesday, August 9, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.

READ MORE >
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.
Share on Twitter Share on Facebook Share on Linkedin

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Share on Twitter Share on Facebook Share on Linkedin
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.
Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.
READ MORE >

Why hypertrophic cardiomyopathy may be widely underdiagnosed

One expert believes the lack of standardization for how diagnostic imaging in conducted and reported has led to a major underdiagnosis of HCM.

READ MORE >
Hari Naidu, MD, explains that inconsistent diagnostic imaging and how it is reported has likely led to a major underdiagnosis of HCM. #ASE #ASE2023 #HCM
Share on Twitter Share on Facebook Share on Linkedin

Why hypertrophic cardiomyopathy may be widely underdiagnosed

Share on Twitter Share on Facebook Share on Linkedin
Hari Naidu, MD, explains that inconsistent diagnostic imaging and how it is reported has likely led to a major underdiagnosis of HCM. #ASE #ASE2023 #HCM
One expert believes the lack of standardization for how diagnostic imaging in conducted and reported has led to a major underdiagnosis of HCM.
READ MORE >

Surgeon sues hospital after being fired for discussing TAVR concerns with media

The vascular surgeon was fired after telling the media about a cardiologist who allegedly performed transcatheter aortic valve replacement without the proper credentials. He is now suing the hospital for wrongful termination and defamation.

READ MORE >
Former managers of a Tampa Florida-based radiology company Advanced Diagnostic Group (ADG) and its employee stock ownership plan (ESOP) retirement benefit manager GreatBanc Trust Co. will pay $19 million to settle a class action lawsuit. The suit alleges they allowed the ESOP’s value to be diverted to managers, directors and their shell companies and away from employee participants. money gavel court lawsuit legal judge judgement
Share on Twitter Share on Facebook Share on Linkedin

Surgeon sues hospital after being fired for discussing TAVR concerns with media

Share on Twitter Share on Facebook Share on Linkedin
Former managers of a Tampa Florida-based radiology company Advanced Diagnostic Group (ADG) and its employee stock ownership plan (ESOP) retirement benefit manager GreatBanc Trust Co. will pay $19 million to settle a class action lawsuit. The suit alleges they allowed the ESOP’s value to be diverted to managers, directors and their shell companies and away from employee participants. money gavel court lawsuit legal judge judgement
The vascular surgeon was fired after telling the media about a cardiologist who allegedly performed transcatheter aortic valve replacement without the proper credentials. He is now suing the hospital for wrongful termination and defamation.
READ MORE >

Featured Articles

Cardiologist William C. Roberts remembered as a ‘true legend in cardiovascular medicine’

Roberts was a passionate cardiac pathologist known for his focus and determination. “To say Bill Roberts will be missed is a massive understatement,” one colleague said. 

READ MORE >
William C. Roberts, MD
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist William C. Roberts remembered as a ‘true legend in cardiovascular medicine’

Share on Twitter Share on Facebook Share on Linkedin
William C. Roberts, MD
Roberts was a passionate cardiac pathologist known for his focus and determination. “To say Bill Roberts will be missed is a massive understatement,” one colleague said. 
READ MORE >

NFL player feeling thankful after AFib diagnosis: ‘I think it’s just the good Lord looking after me’

Tyler Shatley, a veteran offensive lineman with the Jacksonville Jaguars, said he experienced symptoms for years before finally seeking a diagnosis. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

NFL player feeling thankful after AFib diagnosis: ‘I think it’s just the good Lord looking after me’

Share on Twitter Share on Facebook Share on Linkedin
Tyler Shatley, a veteran offensive lineman with the Jacksonville Jaguars, said he experienced symptoms for years before finally seeking a diagnosis. 
READ MORE >

Colchicine before PCI: New research tracks the long-term impact on heart health

Researchers shared long-term follow-up data from the Colchicine-PCI trial, which compared colchicine administration before PCI with a placebo.

READ MORE >
Interventional cardiologists performing PCI
Share on Twitter Share on Facebook Share on Linkedin

Colchicine before PCI: New research tracks the long-term impact on heart health

Share on Twitter Share on Facebook Share on Linkedin
Interventional cardiologists performing PCI
Researchers shared long-term follow-up data from the Colchicine-PCI trial, which compared colchicine administration before PCI with a placebo.
READ MORE >

In Case You Missed It

Exercise plays a key part in HCM management

Matthew Martinez, MD, detailed the many ways HCM care management is changing during an exclusive interview at ASE 2023.

READ MORE >
Matt Martinez, MD, Morristown Medical Center HCM program, explains how hypertrophic cardiomyopathy patient management is changing.
Share on Twitter Share on Facebook Share on Linkedin

Exercise plays a key part in HCM management

Share on Twitter Share on Facebook Share on Linkedin
Matt Martinez, MD, Morristown Medical Center HCM program, explains how hypertrophic cardiomyopathy patient management is changing.
Matthew Martinez, MD, detailed the many ways HCM care management is changing during an exclusive interview at ASE 2023.
READ MORE >

Atrial fibrillation after TAVR linked to much higher risk of death, heart failure

Researchers tracked data from nearly 7,000 TAVR patients for two years, focusing on all-cause mortality and heart failure hospitalizations.

READ MORE >
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.
Share on Twitter Share on Facebook Share on Linkedin

Atrial fibrillation after TAVR linked to much higher risk of death, heart failure

Share on Twitter Share on Facebook Share on Linkedin
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.
Researchers tracked data from nearly 7,000 TAVR patients for two years, focusing on all-cause mortality and heart failure hospitalizations.
READ MORE >

In Other News

Breast cancer overdiagnosis may be common among older women, study contends

The findings point to a "real need for better tools to identify which women may benefit from screening and which breast cancers are unlikely to be progressive." 

READ MORE >
Doctors have increasingly been seeing breast exams with swollen lymph nodes imitating cancer in patients who have received a vaccine, prompting Penn Medicine providers to offer up guidance. mammography mammogram breast cancer
Share on Twitter Share on Facebook Share on Linkedin

Breast cancer overdiagnosis may be common among older women, study contends

Share on Twitter Share on Facebook Share on Linkedin
Doctors have increasingly been seeing breast exams with swollen lymph nodes imitating cancer in patients who have received a vaccine, prompting Penn Medicine providers to offer up guidance. mammography mammogram breast cancer
The findings point to a "real need for better tools to identify which women may benefit from screening and which breast cancers are unlikely to be progressive." 
READ MORE >

UnitedHealthcare eliminating prior authorization for more than 60 radiology services

Impacted procedures will include breast MRI with contrast, bone marrow imaging, gastroesophageal reflux studies and cardiac shunt detection, UHC said.

READ MORE >
UnitedHealthcare UHC UnitedHealth
Share on Twitter Share on Facebook Share on Linkedin

UnitedHealthcare eliminating prior authorization for more than 60 radiology services

Share on Twitter Share on Facebook Share on Linkedin
UnitedHealthcare UHC UnitedHealth
Impacted procedures will include breast MRI with contrast, bone marrow imaging, gastroesophageal reflux studies and cardiac shunt detection, UHC said.
READ MORE >

Industry News

 

Arineta announces SpotLight Duo, the world’s first dedicated cardiovascular and thoracic CT system

Arineta Cardio Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and SpotLight Duo family of cardiovascular CT scanners.   
READ MORE >
 

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup